Estrella Immunopharma, Inc. ( ESLAW) - Stock Earnings
ESLAW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -613174 USD | — USD |
| 2026Q1 | -2.3 million USD | — USD |
| 2026Q2 | -2.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ESLAW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -7.3 million USD | — USD |
| 2025 | -8.8 million USD | — USD |
| 2026 | -13.1 million USD | — USD |
ESLAW
Price: $0.06
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.2 million